| molecular function |
|---|
| | GO:0052657 | | guanine phosphoribosyltransferase activity | | Catalysis of the reaction: GMP + diphosphate = guanine + 5-phospho-alpha-D-ribose 1-diphosphate. |
| | GO:0004422 | | hypoxanthine phosphoribosyltransferase activity | | Catalysis of the reaction: IMP + diphosphate = hypoxanthine + 5-phospho-alpha-D-ribose 1-diphosphate. |
| | GO:0042802 | | identical protein binding | | Interacting selectively and non-covalently with an identical protein or proteins. |
| | GO:0000287 | | magnesium ion binding | | Interacting selectively and non-covalently with magnesium (Mg) ions. |
| | GO:0046872 | | metal ion binding | | Interacting selectively and non-covalently with any metal ion. |
| | GO:0000166 | | nucleotide binding | | Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0042803 | | protein homodimerization activity | | Interacting selectively and non-covalently with an identical protein to form a homodimer. |
| | GO:0016740 | | transferase activity | | Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2. |
| | GO:0016757 | | transferase activity, transferring glycosyl groups | | Catalysis of the transfer of a glycosyl group from one compound (donor) to another (acceptor). |
| biological process |
|---|
| | GO:0046038 | | GMP catabolic process | | The chemical reactions and pathways resulting in the breakdown of GMP, guanosine monophosphate. |
| | GO:0032263 | | GMP salvage | | Any process which produces guanosine monophosphate from derivatives of it, without de novo synthesis. |
| | GO:0046040 | | IMP metabolic process | | The chemical reactions and pathways involving IMP, inosine monophosphate. |
| | GO:0032264 | | IMP salvage | | Any process which produces inosine monophosphate from derivatives of it, without de novo synthesis. |
| | GO:0046083 | | adenine metabolic process | | The chemical reactions and pathways involving adenine, 6-aminopurine, one of the five main bases found in nucleic acids and a component of numerous important derivatives of its corresponding ribonucleoside, adenosine. |
| | GO:0006168 | | adenine salvage | | Any process that generates adenine, 6-aminopurine, from derivatives of it without de novo synthesis. |
| | GO:0021954 | | central nervous system neuron development | | The process whose specific outcome is the progression of a neuron whose cell body is located in the central nervous system, from initial commitment of the cell to a neuronal fate, to the fully functional differentiated neuron. |
| | GO:0021895 | | cerebral cortex neuron differentiation | | The process in which a relatively unspecialized cell acquires specialized features of a neuron residing in the cerebral cortex. |
| | GO:0019835 | | cytolysis | | The rupture of cell membranes and the loss of cytoplasm. |
| | GO:0048813 | | dendrite morphogenesis | | The process in which the anatomical structures of a dendrite are generated and organized. A dendrite is a freely branching protoplasmic process of a nerve cell. |
| | GO:0042417 | | dopamine metabolic process | | The chemical reactions and pathways involving dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline. |
| | GO:0007625 | | grooming behavior | | The specific behavior of an organism relating to grooming, cleaning and brushing to remove dirt and parasites. |
| | GO:0006178 | | guanine salvage | | Any process that generates guanine, 2-amino-6-hydroxypurine, from derivatives of it without de novo synthesis. |
| | GO:0046100 | | hypoxanthine metabolic process | | The chemical reactions and pathways involving hypoxanthine, 6-hydroxy purine, an intermediate in the degradation of adenylate. Its ribonucleoside is known as inosine and its ribonucleotide as inosinate. |
| | GO:0043103 | | hypoxanthine salvage | | Any process that generates hypoxanthine, 6-hydroxy purine, from derivatives of it without de novo synthesis. |
| | GO:0007626 | | locomotory behavior | | The specific movement from place to place of an organism in response to external or internal stimuli. Locomotion of a whole organism in a manner dependent upon some combination of that organism's internal state and external conditions. |
| | GO:0046651 | | lymphocyte proliferation | | The expansion of a lymphocyte population by cell division. |
| | GO:0009116 | | nucleoside metabolic process | | The chemical reactions and pathways involving a nucleoside, a nucleobase linked to either beta-D-ribofuranose (a ribonucleoside) or 2-deoxy-beta-D-ribofuranose, (a deoxyribonucleoside), e.g. adenosine, guanosine, inosine, cytidine, uridine and deoxyadenosine, deoxyguanosine, deoxycytidine and thymidine (= deoxythymidine). |
| | GO:0045964 | | positive regulation of dopamine metabolic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving dopamine. |
| | GO:0051289 | | protein homotetramerization | | The formation of a protein homotetramer, a macromolecular structure consisting of four noncovalently associated identical subunits. |
| | GO:0006164 | | purine nucleotide biosynthetic process | | The chemical reactions and pathways resulting in the formation of a purine nucleotide, a compound consisting of nucleoside (a purine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar. |
| | GO:0006166 | | purine ribonucleoside salvage | | Any process which produces a purine nucleoside from derivatives of it, without de novo synthesis. |
| | GO:0043101 | | purine-containing compound salvage | | Any process that generates a purine-containing compound, any nucleobase, nucleoside, nucleotide or nucleic acid that contains a purine base, from derivatives of them without de novo synthesis. |
| | GO:0001975 | | response to amphetamine | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amphetamine stimulus. Amphetamines consist of a group of compounds related to alpha-methylphenethylamine. |
| | GO:0021756 | | striatum development | | The progression of the striatum over time from its initial formation until its mature state. The striatum is a region of the forebrain consisting of the caudate nucleus, putamen and fundus striati. |
| cellular component |
|---|
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| | GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
Description
